The heat on healthcare’s middlemen — pharmacy benefit managers (PBM) — is increasing, but a tangible solution may still be far off.
Lawmakers grilled PBM executives Tuesday at the third hearing in a series hosted by the House Committee on Oversight and Accountability.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,